Vigil Neuroscience Ownership | Who Owns Vigil Neuroscience?
Vigil Neuroscience Ownership Summary
Vigil Neuroscience is owned by 55.73% institutional investors, 20.70% insiders, and 23.57% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 14.38% of VIGL shares. abrdn Life Sciences Investors is the top mutual fund, with 3.69% of its assets in Vigil Neuroscience shares.
VIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vigil Neuroscience | 55.73% | 20.70% | 23.57% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Atlas venture life science advisors | 5.84M | 14.38% | $9.92M |
| Northpond ventures | 4.21M | 10.57% | $16.86M |
| Siren | 1.99M | 4.91% | $3.38M |
| Artal group | 1.83M | 4.59% | $7.31M |
| Bvf inc/il | 1.81M | 4.47% | $3.08M |
| Sphera funds management | 1.50M | 3.70% | $2.55M |
| Citadel advisors | 1.44M | 3.62% | $5.77M |
| 683 capital management | 1.40M | 3.45% | $2.38M |
| Vanguard group | 975.47K | 2.40% | $1.66M |
| Ensign peak advisors | 703.12K | 1.73% | $1.20M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Northpond ventures | 4.21M | 30.50% | $16.86M |
| Atlas venture life science advisors | 5.84M | 1.21% | $9.92M |
| Pivotal bioventure partners investment advisor | 560.60K | 0.64% | $953.01K |
| Sphera funds management | 1.50M | 0.46% | $2.55M |
| Artal group | 1.83M | 0.19% | $7.31M |
| Siren | 1.99M | 0.15% | $3.38M |
| 683 capital management | 1.40M | 0.15% | $2.38M |
| Ikarian capital | 500.00K | 0.12% | $850.00K |
| Bvf inc/il | 1.81M | 0.10% | $3.08M |
| Trustees of columbia university in the city of new york | 192.97K | 0.05% | $328.05K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 500.00K | 0.12% | 500.00K |
| Woodline partners lp | 488.76K | 0.01% | 344.61K |
| Blair william & co/il | 323.90K | 0.00% | 323.90K |
| Renaissance | 367.30K | 0.00% | 321.30K |
| Abrdn | 528.47K | 0.00% | 293.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -1.55M |
| Point72 asset management | 250.00K | 0.00% | -1.35M |
| Deerfield management company, l.p. (series c) | - | - | -980.31K |
| Stempoint capital lp | - | - | -743.72K |
| Citadel advisors | 1.44M | 0.00% | -722.65K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 500.00K | 0.12% | 500.00K | $850.00K |
| Blair william & co/il | 323.90K | 0.00% | 323.90K | $550.63K |
| Trustees of columbia university in the city of new york | 192.97K | 0.05% | 192.97K | $328.05K |
| Boothbay fund management | 146.75K | 0.01% | 146.75K | $249.47K |
| Squarepoint ops | 113.60K | 0.00% | 113.60K | $193.11K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Nisa investment advisors | -45.00 |
| New york state common retirement fund | -140.00 |
| Royal bank of canada | -471.00 |
| Amalgamated bank | -542.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 51 | -1.92% | 22,613,677 | -18.44% | 55 | 1.19% | 31 | 34.78% | 11 | -38.89% |
| Sep 30, 2024 | 52 | -7.14% | 27,725,211 | 6.11% | 68 | 1.59% | 24 | -22.58% | 18 | 5.88% |
| Jun 30, 2024 | 56 | 7.69% | 26,129,244 | -1.47% | 65 | 1.40% | 31 | 55.00% | 17 | 13.33% |
| Mar 31, 2024 | 52 | 13.04% | 26,518,676 | 6.23% | 68 | 1.66% | 20 | -9.09% | 15 | 25.00% |
| Dec 31, 2023 | 46 | 2.22% | 24,962,629 | -2.27% | 64 | 1.47% | 22 | 37.50% | 12 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn Life Sciences Investors | 1.72M | 3.69% | 368.53K |
| Vanguard Total Stock Mkt Idx Inv | 710.14K | 1.52% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 278.72K | 0.60% | 37.74K |
| BlackRock Health Sciences Term Trust | 225.25K | 0.55% | - |
| Bridgeway Ultra-Small Company Market | 97.16K | 0.24% | - |
| Fidelity Extended Market Index | 109.81K | 0.24% | -699.00 |
| RIM Global Bioscience EUR | 95.00K | 0.20% | 95.00K |
| NT R2000 Value Index Fund - NL | 42.43K | 0.11% | -6.83K |
| NT R2000 Index Fund - NL | 40.34K | 0.10% | -1.64K |
| iShares Micro-Cap ETF | 39.12K | 0.08% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 19, 2024 | Budd Haeberlein Samantha L. | - | Buy | $20.52K |
| Dec 19, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $8.40K |
| Dec 18, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $8.35K |
| Dec 05, 2024 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $11.70K |
| Nov 20, 2023 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $15.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | 4 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | - |
VIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools